This PhD is a biochemist with extensive training in molecular biology. His main interests are in epigenetics molecular biology with special emphasis on behavior and cancer biotechnology and development of novel anticancer drugs. He leads a large group funded by several peer review grants was involved in founding of a biotech company and have several issued patents.